Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tianjin Pharmaceutical Da Ren Tang Group has announced the completion of its disposal of a 13% equity interest in Tianjin TSKF Pharmaceutical Co., Ltd. to Haleon China Co., Ltd. This strategic move, classified as an interested person transaction, reflects the company’s efforts to optimize its investment portfolio and potentially enhance shareholder value.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
